Comparison of the efficacy of two types of hemodialysis catheters: the VectorFlow vs. Palindrome catheters

Abstract

Introduction: Permanent vascular access via catheters is a critical factor for patients who need long-term hemodialysis. Differences in the design and mechanical factors can affect efficacy and survival of the permanent catheters. Modifications in the designs of the catheters can decrease the likelihood of damaging blood vessels as well as thrombosis formation and malfunction of the catheters.
 Objective: To compare survival of VectorFlow, complete symmetry of distal tip and offsetting of its side holes, with those of Palindrome, a complete symmetrical catheter.
 Methods: In this study, 146 CKD (chronic kidney disease) patients who required chronic hemodialysis were divided into VectrFlow (76 subjects) and Palindrome (70 subjects) catheter groups. The patients were followed for six months and the survival rate in each group was determined.
 Results: Mean (+/-SD) survival time in the VectorFlow catheter group (6.55+/-3.88 months, 2 to 24 months) was longer than in the Palindrome catheter group (5.22+/-2.88 months, one to 13 months). After six months, the VectorFlow catheter group (40 cases, 54.8%) had a higher number of patients, having a functioning catheter in place than the Palindrome group (26 cases, 382%); P= 0.04.
 Conclusion: The VectorFlow hemodialysis catheter had a better survival rate after 6 months when compared to the Palindrome catheter. We recommend using this catheter in CKD patients, who require a long-term permanent catheter.

Multifaceted ligand design facilitates chemical- or peptide-mediated linking of hollow gold nanoshells with tuned interparticle distance, interference and cytotoxicities

“…There is contradictory literature regarding the uptake of nanoparticles as a function of their zeta potential which may result from the use of different cell models and/or conditions. [83][84][85][86][87][88] It should also be noted that the ChemLinked-HAuNS and the corresponding monomers had lower cytotoxicities than citrate stabilized HAuNS, whose cell viability was lower than 75% at a concentration as low as OD = 0.5, as reported previously by us using the same 2H11 murine endothelial cell line. 89 The added surface negative charge may indeed cause higher uptake by this cell line under our conditions of evaluation.…”

Targeted therapy of atherosclerosis by zeolitic imidazolate framework-8 nanoparticles loaded with losartan potassium via simultaneous lipid-scavenging and anti-inflammation

“…2c), confirming the effective uptake of IR820@ZIF-8, 41 potentially owing to the positively charged nature of NPs. 42 The normal macrophages also demonstrated a time-dependent uptake of NPs. Nonetheless, the internalization of IR820@ZIF-8 in RAW264.7 cells was significantly lower than activated foam cells at each of the time points (Fig.…”